You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 11, 2024

CHLORTHALIDONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Chlorthalidone, and when can generic versions of Chlorthalidone launch?

Chlorthalidone is a drug marketed by Abbott, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Ani Pharms, Appco, Ascot, Barr Labs Inc, Chartwell Rx, Cosette, Dava Pharms Inc, Inventia, Ivax Pharms, Kv Pharm, Mankind Pharma, Mutual Pharm, Mylan, Novast Labs, Pharmobedient, Pioneer Pharms, Purepac Pharm, Sandoz, Sun Pharm Industries, Sunny, Superpharm, Umedica, Unichem, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, and Zydus Pharms. and is included in fifty-eight NDAs.

The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorthalidone

A generic version of CHLORTHALIDONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHLORTHALIDONE?
  • What are the global sales for CHLORTHALIDONE?
  • What is Average Wholesale Price for CHLORTHALIDONE?
Drug patent expirations by year for CHLORTHALIDONE
Drug Prices for CHLORTHALIDONE

See drug prices for CHLORTHALIDONE

Drug Sales Revenue Trends for CHLORTHALIDONE

See drug sales revenues for CHLORTHALIDONE

Recent Clinical Trials for CHLORTHALIDONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Insel Gruppe AG, University Hospital BernPhase 2
University of BernPhase 2
Roche DiagnosticsPhase 4

See all CHLORTHALIDONE clinical trials

Pharmacology for CHLORTHALIDONE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for CHLORTHALIDONE

US Patents and Regulatory Information for CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms CHLORTHALIDONE chlorthalidone TABLET;ORAL 207813-001 May 10, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novast Labs CHLORTHALIDONE chlorthalidone TABLET;ORAL 206904-001 Mar 30, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Kv Pharm CHLORTHALIDONE chlorthalidone TABLET;ORAL 087312-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz CHLORTHALIDONE chlorthalidone TABLET;ORAL 087118-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.